The Growth Potential of Refractive Surgery for Myopia
Capitalizing on the growth potential of refractive surgery hinges on embracing an array of procedures, challenging conventional mindsets and prioritizing patient-centered care.
By
Yuna Rapoport, MD, MPH
January 1, 2025
Clinical Scorecard: The Growth Potential of Refractive Surgery for Myopia
At a Glance
Category Detail
Condition Myopia Key Mechanisms Increased near work activities, digital screen usage, urbanization, educational pressure, and socioeconomic factors. Target Population Individuals with myopia, particularly those with -3.00 to -10.00 D of myopia. Care Setting Refractive surgery clinics.
Key Highlights
Market for refractive surgery devices projected to grow at a CAGR of 3.9% from 2024 to 2034. Myopia is the leading cause of visual impairment globally. LASIK, PRK, and SMILE are key procedures for moderate to high myopia. EVO ICL offers high correction and preserves corneal integrity. Patient education is crucial for informed decision-making. Guideline-Based Recommendations
Diagnosis
Assess myopia severity and patient history. Evaluate lifestyle factors contributing to myopia. Management
Offer a range of procedures including LASIK, PRK, SMILE, ICL, and RLE. Tailor procedures to individual patient profiles and preferences. Monitoring & Follow-up
Monitor for regression in laser vision correction procedures. Assess patient satisfaction and visual outcomes post-surgery. Risks
Consider risks of dry eye disease with laser procedures. Evaluate potential complications associated with each surgical option. Patient & Prescribing Data
Patients with myopia, particularly those with -3.00 to -10.00 D.
ICL is suitable for a broader range of refractive errors and has lower incidence of higher-order aberrations.
Clinical Best Practices
Educate patients on the benefits and risks of each procedure. Utilize a comprehensive approach to patient selection. Incorporate technological advancements in refractive surgery. References
